chapter 1 How to Create a Therapeutics Committee That Is Scientifically and Economically Sound -- chapter 2 The Public Health Action Plan to Combat Antimicrobial Resistance and the Prevention of Antimicrobial Resistance in Health Care Settings / chapter 3 Why Appropriate Antimicrobial Selection Is Important: Focus on Outcomes / chapter 4 Understanding Pharmacokinetics and Pharmacodynamics: Application to the Antimicrobial Formulary Decision Process / chapter 5 Optimization of Antibacterial Therapy to Minimize Costs, Medication Errors, and Adverse Outcomes / chapter 6 Basic Pharmacoeconomics for the Hospital Decision-Maker -- chapter 7 Measuring the Attributable Costs of Resistant Infections in Hospital Settings / chapter 8 Optimizing Antimicrobial Use and Combating Bacterial Resistance: Benchmarking and Beyond / chapter 9 The Role of Infection Control and Hospital Epidemiology in the Optimization of Antibiotic Use / chapter 10 Antimicrobial Stewardship Initiatives: A Programmatic Approach to Optimizing Antimicrobial Use -- chapter 11 Role of Computer-Assisted Programs in Optimizing the Use of Antimicrobial Agents -- chapter 12 Application of Pharmacodynamic Principles: From Theory to Practice / chapter 13 The Antimicrobial Formulary: Reevaluating Parenteral Cephalosporins in the Context of Emerging Resistance / chapter 14 Early Discharge Strategies: Role of Transitional Therapy Programs / chapter 15 Impact of Guidelines on Antimicrobial Treatment of Respiratory Tract Infections / chapter 16 Abbreviated Courses of Antibacterial Therapy / chapter 17 Antibiotic Cycling Strategies / chapter 18 Outpatient Parenteral Antimicrobial Therapy: Role in Optimizing Length of Hospital Stay / chapter 19 Rational Use of Antifungals for Invasive Fungal Infections in the Institutional Setting.